The UTHealth Houston Adult Cardiovascular Genomics Certificate Program: Efficacy and Impact on Healthcare Professionals.
Autor: | Garner M; University of Alabama at Birmingham., Rajani B; University of Texas Health Science Center at Houston., Vaidya P; University of Texas Health Science Center at Houston., Dayeh SA; University of Texas Health Science Center at Houston., Cecchi AC; University of Texas Health Science Center at Houston., Miyake CC; Baylor College of Medicine., Huff V; University of Texas MD Anderson Cancer Center., Wanat M; University of Houston College of Pharmacy., Wang E; University of Houston College of Pharmacy., Kurzlechner LM; Duke University School of Medicine., Landstrom AP; Duke University School of Medicine., An D; University of Texas Health Science Center at Houston., Liang Y; University of Texas Health Science Center at Houston., Moulik M; University of Pittsburgh School of Medicine., Wong TC; University of Pittsburgh School of Medicine., Cunha SR; University of Texas Health Science Center at Houston., Cannon A; University of Alabama at Birmingham., Holt RL; University of Alabama at Birmingham., Milewicz DM; University of Texas Health Science Center at Houston., Prakash SK; University of Texas Health Science Center at Houston. |
---|---|
Jazyk: | angličtina |
Zdroj: | Research square [Res Sq] 2024 Jun 13. Date of Electronic Publication: 2024 Jun 13. |
DOI: | 10.21203/rs.3.rs-4469272/v1 |
Abstrakt: | Background: The demand for genetic services has outpaced the availability of resources, challenging clinicians untrained in genetic integration into clinical decision-making. The UTHealth Adult Cardiovascular Genomics Certificate (CGC) program trains non-genetic healthcare professionals to recognize, assess, and refer patients with heritable cardiovascular diseases. This asynchronous online course includes 24 modules in three tiers of increasing complexity, using realistic clinical scenarios, interactive dialogues, quizzes, and tests to reinforce learning. We hypothesized that the CGC will increase genomic competencies in this underserved audience and encourage applying genomic concepts in clinical practice. Methods: Required course evaluations include pre- and post-assessments, knowledge checks in each module, and surveys for module-specific feedback. After 6 months, longitudinal feedback surveys gathered data on the long-term impact of the course on clinical practice and conducted focused interviews with learners. Results: The CGC was accredited in September 2022. Principal learners were nurses (24%), nurse practitioners (21%), physicians (16%), and physician assistants. Scores of 283 learners in paired pre- and post-assessments increased specific skills related to recognizing heritable diseases, understanding inheritance patterns, and interpreting genetic tests. Interviews highlighted the CGC's modular structure and linked resources as key strengths. Learners endorsed confidence to use genetic information in clinical practice, such as discussing genetic concepts and risks with patients and referring patients for genetic testing. Learners were highly likely to recommend the CGC to colleagues, citing its role in enhancing heritable disease awareness. Conclusions: The CGC program effectively empowers non-genetic clinicians to master genomic competencies, fostering collaboration to prevent deaths from heritable cardiovascular diseases, and potentially transforming healthcare education and clinical practice. Competing Interests: Authors Melyssa Garner, Bansari Rajani, Priyanka Vaidya, Samer Abu Dayeh, Alana Cecchi, Christina Miyake, Vicki Huff, Matthew Wanat, Elisabeth Wang, Leonie Kurzlechner, Andrew Landstrom, Daniel An, Yafen Liang, Mousumi Moulik, Shane Cunha, Ashley Cannon, R. Lynn Holt, Dianna Milewicz, and Siddharth Prakash declare that they have no Conflicts of interest. Timothy Wong is site principal investigator for clinical trials related to hypertrophic cardiomyopathy sponsored by Bristol Myers Squibb, Cytokinetics, and Tenaya Therapeutics and serves as an unpaid member of advisory boards for Bristol Myers Squibb and Cytokinetics. |
Databáze: | MEDLINE |
Externí odkaz: |